Kan, N <br/><br/>
Therapeutic efficacy of sequential therapy with OK-432, cyclophosphamide, IL2-cultured lymphocytes and in vivo IL2 against advanced murine plasmacytoma.  [electronic resource] 

 -  Biotherapy (Dordrecht, Netherlands)  1989 
 - 197-206 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0921-299X 
<br/><br/><label>Standard No.: </label>10.1007/BF02170888  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Biological Products--therapeutic use<br/>Combined Modality Therapy<br/>Cyclophosphamide--therapeutic use<br/>Immunization, Passive<br/>Interleukin-2--therapeutic use<br/>Killer Cells, Lymphokine-Activated--immunology<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Peritoneal Cavity--cytology<br/>Picibanil--therapeutic use<br/>Plasmacytoma--immunology<br/>Spleen--cytology